J&J Hips and Mesh under Government scanner

Boston, MA 02/25/2013 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ) has disclosed that different government investigations are underway into various alleged faults in its hip devices and surgical mesh that is sold in the world market. Johnson & Johnson (NYSE:JNJ) recalled over 93,000 pieces from across the world after announcing that 12 percent of the devices had failed in the UK market. The world’s largest health-care products seller is in the midst of a lawsuit storm with over 10,000 ASR hip-related suits and 1,800 Gynecare Prolift- related lawsuits filed by consumers in the U.S. All the hip-related cases claim that there was a defect in the designing of the devices and that Johnson & Johnson (NYSE:JNJ) had failed to send out warnings about any possible problems.  The first of these cases is now being fought out in the Atlantic City state court.

Investigations in progress

Johnson & Johnson (NYSE:JNJ) discontinued the sales of Prolift and three other mesh devices only due to the fact that they were not commercially viable and that the pull-back had nothing to do with either their effectiveness or their safety. The U.S government is also investigating the possibility of false statements or false claims being submitted. Johnson & Johnson (NYSE:JNJ) the Brunswick, the New Jersey-based company said that it will co-operate completely with the Massachusetts U.S. Attorney’s Office and the Justice Department’s civil division in the informal request that it has received with reference to the use and marketing of the hips. All necessary documents will be produced and the company will be forthcoming with all explanations and clarifications.

Shares of Johnson & Johnson (NYSE:JNJ) went down by 0.01% to close at $76.25

For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.

Published by Donna Fago

I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.